Skip to main content
. 2021 Feb 24;14(1):1892309. doi: 10.1080/16549716.2021.1892309

Figure 2.

Figure 2.

Proportion of clinical trial participants by ethnicity in vaccine trials for Pfizer/BNT162b2, Astrazeneca/ChadOx1 and Moderna/mRNA-1273